LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal toxicity.

被引：0
|
作者：
Orchard, K [1 ]
Giles, C [1 ]
Apperley, J [1 ]
Goldman, JM [1 ]
Kanfer, EJ [1 ]
Samson, D [1 ]
机构：
[1] HAMMERSMITH HOSP,NHS TRUST,LONDON,ENGLAND
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1855 / 1855
页数：1
相关论文
共 50 条
  • [1] LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity.
    Orchard, K
    Lyttelton, MP
    Abrahamson, G
    Stern, S
    Abboudi, Z
    McGuigan, D
    Giles, C
    Kanfer, EJ
    Samson, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 174 - 174
  • [2] Lace(lomustine, ARA-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity
    Orchard, K
    Lyttelton, MP
    Abrahamson, G
    Stem, S
    Abboudi, Z
    McGuigan, D
    Giles, C
    Kanfer, EJ
    Samson, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 969 - 969
  • [3] Long-term outcome after LACE (lomustine, ara-C, cyclophosphamide, etoposide) conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma
    Perz, JB
    Giles, C
    Szydlo, RM
    Wagner, S
    Sanz, J
    Chaidos, A
    Apperley, JF
    MacDonald, D
    Kanfer, E
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S240 - S240
  • [4] Thiotepa, Etoposide, Cyclophosphamide, ARA-C and Melphalan (TECAM) conditioning protocol for autologous stem cell transplantation - An alternative non BCNU containing regimen
    Grisariu, S.
    Shapira, M. Y.
    Or, R.
    Avni, B.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S441 - S441
  • [5] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma
    Patir, P.
    Soyer, N.
    Sahin, F.
    Saydam, G.
    Tobu, M.
    Tombuloglu, M.
    Vural, F.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S336 - S337
  • [6] Comparison between BEAM and lomustine, Ara-C, etoposide and melphalan as conditioning regimen before stem cell transplantation. A single-centre experience
    Grillo, G.
    Marenco, P.
    Bertani, G.
    Zucchetti, E.
    Turrini, M.
    Brasca, P.
    Gabutti, C.
    Morra, E.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S194 - S195
  • [7] Long-term outcome after LACE (Lomustine, Ara-C, Cyclophosphamide, Etoposide) conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: A single centre experience.
    Perz, JB
    Giles, CM
    MacDonald, D
    Apperley, JF
    Kanfer, EJ
    [J]. BLOOD, 2005, 106 (11) : 464B - 464B
  • [8] EXTRAMEDULLARY TOXICITY OF A CONDITIONING REGIMEN CONTAINING BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE IN 84 PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CRILLEY, P
    TOPOLSKY, D
    STYLER, MJ
    BERNSTEIN, E
    RESNICK, K
    MULLANEY, R
    BULOVA, S
    BRODSKY, I
    MARKS, DI
    [J]. BONE MARROW TRANSPLANTATION, 1995, 15 (03) : 361 - 365
  • [9] THE COMPARISON OF BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C AND MELPHALAN) AND BEAM (BCNU, ETOPOSIDE, ARA-C AND MELPHALAN) CONDITIONING REGIMENS IN LYMPHOMA PATIENTS TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION
    Mikhailova, N.
    Kondakova, E.
    Maramy-Zonouzi, N.
    Bondarenko, S.
    Podoltseva, E.
    Medvedeva, N.
    Popova, M.
    Ryabchikova, V.
    Afanasiev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S448 - S449
  • [10] Allogeneic bone marrow transplantation for multiple myeloma (MM) using BVAC (BCNU, etoposide, ARA-C, cyclophosphamide) and TBI as preparative regimen.
    deMagalhaes-Silverman, M
    Hohl, RJ
    Lee, CK
    Davis, C
    Scott, S
    Gingrich, RD
    [J]. BLOOD, 1998, 92 (10) : 322B - 322B
12345